CH
CHRS
Coherus BioSciences
$1.33
1M +13.7%
3M -6.3%
YTD -2.9%
as of 2026-09-11
+Watchlist
↑↓ next ticker
· ⌘+↑↓ or scroll to zoom
· ←→ pan · 0 reset
▲ buy
▼ sell · size ≈ trade size
· ─ moving averages ·
click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Seasonality
Weak window historically
Next 30 days (to Oct 14): -10.6% median,
27% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 32
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is +0.07%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.89 -0.3% · Seasonal tilt (11y) -0.4%
$1M/day volume
81% volatility
+2% 1-year
52-week range · 16% of the way up · -49% from the high
$1.09$2.62
Congressional trades in CHRS
Full tracker →
1 member · 0 buys / 1 sells
· $15K–$50K disclosed · latest filing Feb 9, 2023.
| SELL |
ST Shri Thanedar
· traded Jan 23, 2023 |
$15K–$50K |
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.